Clinical Trial Update: A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma [Phase 1]

View source ↗

Summary

First-in-human phase I/IIa trial evaluating DA 3501 in advanced gastric or gastroesophageal cancer and pancreatic ductal adenocarcinoma; currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• DA 3501

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Gastric (Stomach) Cancer, GastroEsophageal Cancer | Phase 1 | Status: NOT_YET_RECRUITING